Lenacapavir is a revolutionary long-acting injectable drug that offers six months of protection with just two annual ...

The drug, Lenacapavir, is the world's first injectable Pre-Exposure Prophylaxis (PrEP). According to the World Health ...

South Africa has become the first African country to register the revolutionary twice-a-year anti-HIV jab, lenacapavir (LEN).

The South African Health Products Regulatory Authority has approved Lenacapavir, a long-acting injection that prevents HIV ...

An HIV prevention jab that provides six months of protection at a time was given the green light by South Africa's medicines regulator. The approval helps to clear the way for a limited public sector ...

The South African Health Products Regulatory Authority has approved a new HIV prevention injection called Lenacapavir.

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the ...

The South African Health Products Regulatory Authority (SAHPRA) has announced the registration of lenacapavir, making South ...

South Africa’s Health Product Regulatory Authority (SAHPRA) has approved the use of the twice-yearly HIV prevention drug, lenacapavir. In a statement released on 27 October, the regulatory body said ...